Xeris Biopharma Holdings Inc (NASDAQ:XERS) Stock Sees Buying Activities After The News
Biopharmaceutical company Xeris Biopharma Holdings Inc (NASDAQ:XERS), which is involved in the development of specific therapies in the fields of neurology, gastroenterology and endocrinology, was in focus among investors on Monday. Market Reaction: On Monday, XERS stock increased by 5.50% at $1.92 with more than 6.01 million shares, compared to its average volume of 3.44 million shares. The stock has moved within a range of $1.9000 – 2.1500 after opening…